Saudi Journal of Gastroenterology
Home About us Instructions Submission Subscribe Advertise Contact Login    Print this page  Email this page Small font sizeDefault font sizeIncrease font size 
Users Online: 1509 

    Article Cited by others

ORIGINAL ARTICLE

Real-world single-center experience with entecavir and tenofovir disoproxil fumarate in treatment-naïve and experienced patients with chronic hepatitis B

Kim Young Min, Shin Hyun Phil, Lee Joung Il, Joo Kwang Ro, Cha Jae Myung, Jeon Jung Won, Yoon Jin Young, Kwak Min Seob

Year : 2018| Volume: 24| Issue : 6 | Page no: 326-335

   This article has been cited by
 
1 Real-World Safety and Effectiveness of Oral Nucleos(t)ide Analogs in the Treatment of Chronic Hepatitis B Virus Infection
Robert J. Wong, Ramsey C. Cheung
Current Hepatology Reports. 2021;
[Pubmed]  [Google Scholar] [DOI]
2 Effects of Tenofovir vs Entecavir on Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection: A Systematic Review and Meta-analysis
Won-Mook Choi, Jonggi Choi, Young-Suk Lim
Clinical Gastroenterology and Hepatology. 2021; 19(2): 246
[Pubmed]  [Google Scholar] [DOI]
3 Effects of Tenofovir vs Entecavir on Risk of Hepatocellular Carcinoma in Patients With CHB: A Comment for Moving Forward
Bao-Hong Yuan, Yan-Kun Zhu, Ru-Hong Li
Clinical Gastroenterology and Hepatology. 2021;
[Pubmed]  [Google Scholar] [DOI]
4 Differential Effectiveness of Tenofovir and Entecavir for Prophylaxis of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Depending on Coexisting Cirrhosis and Prior Exposure to Antiviral Therapy
Seogsong Jeong, Yuri Cho, Sang Min Park, Won Kim
Journal of Clinical Gastroenterology. 2021; Publish Ah
[Pubmed]  [Google Scholar] [DOI]
5 The strategy and efficacy of prophylaxis against hepatitis B virus recurrence after liver transplantation for HBV-related diseases in the era of potent nucleos(t)ide analogues: A meta-analysis
Ming Shu Li, Zhou Hua Hou, Guo Zhu Yao, De Ming Tan
Journal of Digestive Diseases. 2021; 22(2): 91
[Pubmed]  [Google Scholar] [DOI]
6 Comparative Effectiveness of Entecavir Versus Tenofovir for Preventing Hepatocellular Carcinoma in Patients with Chronic Hepatitis B: A Systematic Review and Meta-Analysis
Shravan Dave, Sooyoung Park, M. Hassan Murad, Abbey Barnard, Larry Prokop, Leon A. Adams, Siddharth Singh, Rohit Loomba
Hepatology. 2021; 73(1): 68
[Pubmed]  [Google Scholar] [DOI]
7 Secondary prevention for hepatocellular carcinoma in patients with chronic hepatitis B: are all the nucleos(t)ide analogues the same?
Terry Cheuk-Fung Yip, Jimmy Che-To Lai, Grace Lai-Hung Wong
Journal of Gastroenterology. 2020; 55(11): 1023
[Pubmed]  [Google Scholar] [DOI]
8 Comparison of tenofovir versus entecavir on reducing incidence of hepatocellular carcinoma in chronic hepatitis B patients: A systematic review and meta-analysis
Lihu Gu, Qigu Yao, Zefeng Shen, Ying He, Derry Minyao Ng, Tong Yang, Bangsheng Chen, Ping Chen, Feiyan Mao, Qili Yu
Journal of Gastroenterology and Hepatology. 2020; 35(9): 1467
[Pubmed]  [Google Scholar] [DOI]
9 Magnitude of and prediction for risk of hepatocellular carcinoma in patients with chronic hepatitis B taking entecavir or tenofovir therapy: A systematic review
Cheng-Hao Tseng, Chao-Ming Tseng, Jia-Ling Wu, Yao-Chun Hsu, Hashem B. El-Serag
Journal of Gastroenterology and Hepatology. 2020; 35(10): 1684
[Pubmed]  [Google Scholar] [DOI]
10 Tenofovir versus entecavir in prevention of hepatocellular carcinoma and mortality in patients with chronic hepatitis B
Faisal Kamal, Muhammad Ali Khan, Aijaz Ahmed, Satheesh Nair
Gut. 2020; 69(11): 2054
[Pubmed]  [Google Scholar] [DOI]
11 Hepatocellular carcinoma and death and transplantation in chronic hepatitis B treated with entecavir or tenofovir disoproxil fumarate
Yeonjung Ha, Young Eun Chon, Mi Na Kim, Joo Ho Lee, Seong Gyu Hwang
Scientific Reports. 2020; 10(1)
[Pubmed]  [Google Scholar] [DOI]

 

Read this article